Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Aeras and CNBG Partner on TB Vaccine

publication date: Jan 10, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Aeras, a US-based non-profit dedicated to developing effective TB vaccines and biologics, has partnered with the China National Biotec Group (CNBG) to develop a recombinant form of Bacille Calmette-Guerin (BCG), the only TB vaccine currently approved. Aeras will provide financial support and technical expertise to CNBG as part of the partnership. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...